More about High-Yield Cash Accounts with M1
Brokerage Accounts
Retirement Accounts
Other Accounts
Quotes are delayed by 15 minutes.
1D
1W
1M
3M
6M
YTD
1Y
2Y
5Y
ALL
Market cap
$195278724
EPS
-3.45
P/E ratio
--
Price to sales
0.99
Dividend yield
--
Beta
1.722392
Previous close
$11.74
Today's open
$11.63
Day's range
$11.26 - $11.79
52 week range
$3.71 - $15.16
show more
CEO
Ido Schoenberg
Employees
562
Headquarters
Boston, MA
Exchange
New York Stock Exchange
Shares outstanding
17220346
Issue type
Common Stock
Healthcare
Healthcare Providers & Services
Amwell Will Support New Federally Funded Research to Improve Engagement and Outcomes in Mental Health Care for Veterans and Service Members
BOSTON, Nov. 10, 2026 (GLOBE NEWSWIRE) -- Amwell® (NYSE: AMWL) today announced a research agreement with The University of California, Los Angeles (UCLA) to study how digital mental health support can help veterans and transitioning service members connect with care for depression. This work leverages SilverCloud® by Amwell®, the digital cognitive behavioral therapy program delivered on the Amwell Platform, in research supported by the U.S. Department of Veterans Affairs (VA) and Department of War (DoW).
GlobeNewsWire • Nov 10, 2026

American Well (AMWL) Shows Fast-paced Momentum But Is Still a Bargain Stock
American Well (AMWL) could be a great choice for investors looking to buy stocks that have gained strong momentum recently but are still trading at reasonable prices. It is one of the several stocks that made it through our 'Fast-Paced Momentum at a Bargain' screen.
Zacks Investment Research • Nov 10, 2026

American Well (AMWL) Could Find a Support Soon, Here's Why You Should Buy the Stock Now
American Well (AMWL) witnesses a hammer chart pattern, indicating support found by the stock after losing some value lately. This coupled with an upward trend in earnings estimate revisions could mean a trend reversal for the stock in the near term.
Zacks Investment Research • Nov 10, 2026

Amwell makes grant to new employees under inducement plan
BOSTON, Nov. 06, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based software platform for technology-enabled healthcare, announces that on November 6, Amwell made grants of RSUs covering an aggregate of 5,761 shares of its Class A common stock to two new employees. The grants were offered as material inducement to the employees' employment with Amwell. The RSUs will vest as follows, subject to the applicable employee's continued employment through the applicable vesting date: 25% of the RSUs will vest upon the first anniversary of the grant date (“Initial Vesting Date”), and the remaining 75% of the RSUs will vest in equal pro rata increments every three months thereafter (beginning on the first calendar day of the month following the date that is three months following the Initial Vesting Date) for three years until such RSUs are vested in full.
GlobeNewsWire • Nov 6, 2026

Amwell Says One-Third of Adults Now Using AI Health Tools
American Well Corp. (Amwell) says is seeing a fundamental evolution in how corporate buyers and consumers navigate digital medicine.
PYMNTS • Nov 4, 2026

What American Well (AMWL) Said on Its Q3 Earnings Call
American Well NYSE: AMWL, known as Amwell, reported third-quarter 2026 revenue above its guidance range and narrowed its adjusted EBITDA loss as stronger visit volumes and cost controls helped support its target of reaching positive adjusted EBITDA and operating cash flow in the fourth quarter.
MarketBeat • Nov 4, 2026

American Well Corporation (AMWL) Q3 2026 Earnings Call Transcript
American Well Corporation (AMWL) Q3 2026 Earnings Call Transcript
Seeking Alpha • Nov 4, 2026

Amwell® Announces Results for the Third Quarter 2026
BOSTON, Nov. 03, 2026 (GLOBE NEWSWIRE) -- Amwell ® (NYSE: AMWL), a leading provider of a comprehensive SaaS-based technology-enabled healthcare platform, today announced financial results for the third quarter ended September 30, 2026. “Health plans and employers want engagement, outcomes and proof, and Amwell's single platform is built to deliver all three,” said Dr. Ido Schoenberg, Chairman and CEO of Amwell.
GlobeNewsWire • Nov 3, 2026

American Well Corporation (AMWL) Reports Q3 Loss, Tops Revenue Estimates
American Well Corporation (AMWL) came out with a quarterly loss of $0.67 per share versus the Zacks Consensus Estimate of a loss of $0.66. This compares to a loss of $1.74 per share a year ago.
Zacks Investment Research • Nov 4, 2026

American Well (AMWL) Surges 6.1%: Is This an Indication of Further Gains?
American Well (AMWL) saw its shares surge in the last session with trading volume being higher than average. The latest trend in earnings estimate revisions may not translate into further price increase in the near term.
Zacks Investment Research • Oct 30, 2026

¹ Disclosures

Open an M1 investment account to buy and sell American Well Corporation Class A commission-free¹. Build wealth for the long term using automated trading and transfers.